Medical/Pharmaceuticals

NCCN 2025 Annual Conference Illustrates the Critical Impact of Cancer Research on Improving Lives

The National Comprehensive Cancer Network celebrated its 30th anniversary with a series of presentations on cancer care practice changes—in both treatment and administration—plus new research, and other changes for the oncology workforce and the patients they serve. ORLANDO, Fla., April 2, 2025 ...

2025-04-02 21:06 2810

"miraDry Releases the First Ever Sweat Scope Report, Shedding Light on Underarm Sweat and Odor in Menopause"

NEWPORT BEACH, Calif., April 2, 2025 /PRNewswire/ -- Today, miraDry, Inc., in partnership with the International Hyperhidrosis Society (IHhS), announced the results of a landmark study focusing on a rarely discussed aspect of menopause: underarm sweat and odor. The study, titled "Sweat Scope: The...

2025-04-02 21:00 3204

FWD Hong Kong forms partnerships to launch "Talk2Me Peer Supporter Training Certificate Programme" and "JA SparktheDream Wellness Workshop" to promote youth mental health

HONG KONG, April 2, 2025 /PRNewswire/ -- Youth mental health is one of the most widely discussed social issues inHong Kong. This underscores the need for mental health support for youth. In response, FWD Hong Kong ("FWD") has collaborated with two non-profit organisations,KELY Support Group and J...

2025-04-02 19:12 4779

Fosun International 2024 Annual Results Presentation: Aiming for RMB10 Billion in Future Industrial Operation Profit

HONG KONG and SHANGHAI, April 2, 2025 /PRNewswire/ -- On 1 April 2025, Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group") held its 2024 annual results presentation inShanghai. The results presentation was attended b...

2025-04-02 13:51 5948

Human Frontier Science Program: Research Grants Awarded to 104 of the Most Pioneering Scientists from 30 Nations

STRASBOURG, France, April 2, 2025 /PRNewswire/ -- To pioneer new frontiers in life science research, the Human Frontier Science Program has awarded 104 of the world's most ingenious scientists from 30 nations with 2025 HFSP Research Grants and the first round of the new Accelerator Grants. 

2025-04-02 08:10 3439

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

MELBOURNE, Australia, April 2, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx (89 Zr-olaratumab) in patients with advanced, metastatic soft tissue sarcoma...

2025-04-02 03:30 3513

Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer's Dementia

TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and Welfare as a new drug, indicated for suppression of progressio...

2025-03-31 21:35 4191

Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist

-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration. -As previously disclosed, oral tablet formulation of small molecule ASC30 demonstrated potentially ...

2025-03-31 19:00 3482

Clinical Study demonstrates Kerry Group Supplement Solution Sensoril® Ashwagandha Supports Quality of Life for Post-Menopausal Women

Sensoril® Ashwagandha is among Kerry's portfolio of solutions tailored to meet women's unique health needs   SINGAPORE, March 31, 2025 /PRNewswire/ -- Sensoril® ashwagandha  — a science-backed ingredie...

2025-03-31 17:30 4131

Revenue Soars 44%, Basecare Medical (2170.HK) Advances Toward Global Intelligent Manufacturing

SUZHOU, China, March 31, 2025 /PRNewswire/ -- Amid frequent pro-fertility policy updates, Basecare Medical, a pioneer in the assisted reproductive IVD sector with full fertility health industry chain coverage, released its stellar 2024 performance report. The company achieved annual revenue of ne...

2025-03-31 17:01 6571

Reaffirming Leadership: Medit's Strong Presence at IDS 2025

COLOGNE, Germany and SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Medit, a global leader in digital dentistry solutions, made a significant impact at International Dental (IDS) 2025 by unveiling its latest innovations in intraoral scanning and comprehensive digital workflows. Alongside new ...

2025-03-31 15:00 4472

S Spine Hospital Launches T-Shirt to Raise Awareness About Back Pain

BANGKOK, March 31, 2025 /PRNewswire/ -- S Spine Hospital, a specialist in spine, has unveiled "THE SPINE T-SHIRT," a health communication initiative designed to transform how people perceive and understand spinal health issues. S Spine Hosp...

2025-03-31 14:52 2558

Ceva Animal Health renews its shareholding structure with all its long-standing partners and opens its capital to Mérieux Institute and ARCHIMED to accelerate its growth.

LIBOURNE, France, March 31, 2025 /PRNewswire/ -- Ceva Animal Health  (Ceva), the world's fifth-largest animal health company, announces the restructuring of its capital. All investors, whether "Friends of Ceva" or pure investors led by Temasek, have renewed their investmen...

2025-03-31 14:12 4606

Acer Medical Debuts VeriSee AI-assisted Screening Solutions at the Malaysian Ophthalmology Society Annual Congress

Collaboration with Intel® for AI-powered medical screening optimizations TAIPEI, March 31, 2025 /PRNewswire/ -- Acer Medical has recently launched its AI-assisted screening software, VeriSee Diabetic Retinopathy and VeriSee Age-Related Macular Degeneration. These innovative solutions will be show...

2025-03-31 11:32 3452

Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

SAN FRANCISCO and SUZHOU, China, March 31, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2025-03-31 09:22 4325

Human Frontier Science Program: Fellowships Awarded to 60 Pioneering Postdoctoral Scientists from 25 Nations

STRASBOURG, France, March 31, 2025 /PRNewswire/ -- To foster the next generation of life science research, 60 of the world's top emerging scientists from 25 nations have won 2025 Human Frontier Science Program (HFSP) Fellowships.

2025-03-31 08:00 2853

AIM Vaccine reduces losses by nearly 90% in 2024, with the iterative major product series opening up space for explosive growth in performance

HONG KONG, March 31, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, 2025, the company recorded revenues of RMB 1,285 million in 2024, an increase of 8.2% compared to the previous year, with significa...

2025-03-31 08:00 5904

Fosun International Announces 2024 Annual Results: Total Revenue Reaches RMB192.14 Billion, Industrial Operation Profit Amounts to RMB4.9 Billion, Overall Operational Fundamentals Remain Stable

2024 Annual Results Highlights: * Total revenue reached RMB192.14 billion; * Industrial operation profit amounted to RMB4.9 billion; * Total revenue generated by the four core subsidiaries amounted to RMB134.65 billion, accounting for 70.1% of the Group's total revenue; * Total debt to tot...

2025-03-30 21:54 5001

Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification

* Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to utilize BRII-179 to identify patients who are immune responders and have the potential to achieve higher HBsAg loss at EOT * 48-week EOT data from Cohort 1-3 of the ENSURE study clearly suggests the a...

2025-03-30 19:10 6489

LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%

SHENZHEN, China, March 30, 2025 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiari...

2025-03-30 01:02 6819
1 ... 108109110111112113114 ... 381